tiprankstipranks
Trending News
More News >
Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ:MDGL
US Market

Madrigal Pharmaceuticals (MDGL) Income Statement

Compare
1,336 Followers

Madrigal Pharmaceuticals Income Statement

Last quarter (Q4 2025), Madrigal Pharmaceuticals's total revenue was $321.08M, an increase of 210.77% from the same quarter last year. In Q4, Madrigal Pharmaceuticals's net income was $-58.58M. See Madrigal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 958.40M$ 180.13M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 902.25M$ 173.90M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 1.20B$ 671.77M$ 380.50M$ 293.57M$ 242.48M
Depreciation and Amortization
$ 1.51M$ 1.10M$ 527.00K$ 467.00K$ 405.00K
EBITDA
$ -264.47M$ -450.13M$ -360.39M$ -290.92M$ -241.44M
Operating Income
$ -300.10M$ -497.88M$ -380.50M$ -293.57M$ -242.48M
Other Income/Expenses
$ 11.81M$ 31.98M$ 6.87M$ -1.78M$ 636.00K
Pretax Income
$ -288.28M$ -465.89M$ -373.63M$ -295.35M$ -241.85M
Net Income
$ -288.28M$ -465.89M$ -373.63M$ -295.35M$ -241.85M
Per Share Metrics
Basic EPS
$ -12.85$ -21.90$ -19.99$ -17.23$ -14.63
Diluted EPS
$ -12.85$ -21.90$ -19.99$ -17.23$ -14.63
Weighted Average Shares Outstanding
22.43M 21.27M 18.69M 17.14M 16.54M
Weighted Average Shares Outstanding (Diluted)
22.43M 21.27M 18.69M 17.14M 16.54M
Currency in USD

Madrigal Pharmaceuticals Earnings and Revenue History